Advertisement
Advertisement
U.S. Markets close in 2 hrs 10 mins
Advertisement
Advertisement
Advertisement
Advertisement

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
20.41-0.82 (-3.85%)
As of 01:50PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close21.23
Open21.21
Bid20.23 x 900
Ask20.28 x 800
Day's Range20.20 - 21.21
52 Week Range17.33 - 55.42
Volume188,244
Avg. Volume573,773
Market Cap1.165B
Beta (5Y Monthly)1.88
PE Ratio (TTM)N/A
EPS (TTM)-3.59
Earnings DateFeb 22, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est61.78
  • GlobeNewswire

    Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    NEW YORK and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis™ Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that on February 1, 2023, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 12,500 shares of the Company’s common sto

  • GlobeNewswire

    Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences

    NEW YORK and SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that Kimberly Blackwell, MD, Chief Executive Officer of Zentalis, will participate in fireside chats at two upcoming investor conferences. Presentation Details: Event: Guggenheim Healthcare T

  • Simply Wall St.

    We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely

    Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Advertisement
Advertisement